Page last updated: 2024-09-05

avasimibe and Chronic Hepatitis C

avasimibe has been researched along with Chronic Hepatitis C in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, H; Hu, L; Li, J; Li, YP; Peng, T; Qiu, X; Xia, H; Xiao, J; Yao, W	1

Other Studies

1 other study(ies) available for avasimibe and Chronic Hepatitis C

Article	Year
Avasimibe: A novel hepatitis C virus inhibitor that targets the assembly of infectious viral particles. Antiviral research, 2017, Volume: 148 Topics: Acetamides; Acetates; Antiviral Agents; Apolipoproteins B; Apolipoproteins E; Carrier Proteins; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Viral; Genotype; Hepacivirus; Hepatitis C, Chronic; Host-Pathogen Interactions; Humans; Lipid Metabolism; Lipid Regulating Agents; RNA, Small Interfering; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Virion; Virus Assembly	2017

Article

Year

Avasimibe: A novel hepatitis C virus inhibitor that targets the assembly of infectious viral particles.

Antiviral research, 2017, Volume: 148

Topics: Acetamides; Acetates; Antiviral Agents; Apolipoproteins B; Apolipoproteins E; Carrier Proteins; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Viral; Genotype; Hepacivirus; Hepatitis C, Chronic; Host-Pathogen Interactions; Humans; Lipid Metabolism; Lipid Regulating Agents; RNA, Small Interfering; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Virion; Virus Assembly

2017